Cargando…

Hepatitis B and C in dialysis units in Kosova

BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important causes of morbidity and mortality of hemodialysis (HD) patients. This study aimed to investigate the epidemiological and clinical features of HCV and HBV infections in six different HD units in Kosova. Five hund...

Descripción completa

Detalles Bibliográficos
Autores principales: Telaku, Skender, Fejza, Hajrullah, Elezi, Ymer, Bicaj, Teuta
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694791/
https://www.ncbi.nlm.nih.gov/pubmed/19497116
http://dx.doi.org/10.1186/1743-422X-6-72
_version_ 1782168123534737408
author Telaku, Skender
Fejza, Hajrullah
Elezi, Ymer
Bicaj, Teuta
author_facet Telaku, Skender
Fejza, Hajrullah
Elezi, Ymer
Bicaj, Teuta
author_sort Telaku, Skender
collection PubMed
description BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important causes of morbidity and mortality of hemodialysis (HD) patients. This study aimed to investigate the epidemiological and clinical features of HCV and HBV infections in six different HD units in Kosova. Five hundred and eighty-three end-stage kidney disease (ESKD) patients on maintenance HD from six HD centers in Kosova (358 female, 225 male, mean age 54,8 years (16–66) were included in this study. Data from databank of the National Blood Bank in Prishtina, as well as the data from the databank of the Transfusion Centers in Regional hospitals in Prizren, Peja, Gjilan, Mitrovica and Gjakova were taken in this study. Clinical data such as age, sex, HBsAg and anti-HCV antibody and primary causes of ESKD were examined. Serological markers for HBV and HCV were determined with immunoenzymatic assay (ELISA). RESULTS: The T-test and x(2 )test were used to analyze the significance of the results. Among our HD patients HBsAg and anti-HCV antibody prevalence rate was 12%, respectively 43%. Chronic nephritis was a more frequent cause of ESKD among our HD patients. With unknown etiology were 23, 5% from them. CONCLUSION: HBV and HCV prevalence in our HD patients is still high. These data emphasize the need for stricter adherence to infection control, barrier precaution and preventive behaviors with all patients.
format Text
id pubmed-2694791
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26947912009-06-11 Hepatitis B and C in dialysis units in Kosova Telaku, Skender Fejza, Hajrullah Elezi, Ymer Bicaj, Teuta Virol J Research BACKGROUND: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are important causes of morbidity and mortality of hemodialysis (HD) patients. This study aimed to investigate the epidemiological and clinical features of HCV and HBV infections in six different HD units in Kosova. Five hundred and eighty-three end-stage kidney disease (ESKD) patients on maintenance HD from six HD centers in Kosova (358 female, 225 male, mean age 54,8 years (16–66) were included in this study. Data from databank of the National Blood Bank in Prishtina, as well as the data from the databank of the Transfusion Centers in Regional hospitals in Prizren, Peja, Gjilan, Mitrovica and Gjakova were taken in this study. Clinical data such as age, sex, HBsAg and anti-HCV antibody and primary causes of ESKD were examined. Serological markers for HBV and HCV were determined with immunoenzymatic assay (ELISA). RESULTS: The T-test and x(2 )test were used to analyze the significance of the results. Among our HD patients HBsAg and anti-HCV antibody prevalence rate was 12%, respectively 43%. Chronic nephritis was a more frequent cause of ESKD among our HD patients. With unknown etiology were 23, 5% from them. CONCLUSION: HBV and HCV prevalence in our HD patients is still high. These data emphasize the need for stricter adherence to infection control, barrier precaution and preventive behaviors with all patients. BioMed Central 2009-06-04 /pmc/articles/PMC2694791/ /pubmed/19497116 http://dx.doi.org/10.1186/1743-422X-6-72 Text en Copyright © 2009 Telaku et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Telaku, Skender
Fejza, Hajrullah
Elezi, Ymer
Bicaj, Teuta
Hepatitis B and C in dialysis units in Kosova
title Hepatitis B and C in dialysis units in Kosova
title_full Hepatitis B and C in dialysis units in Kosova
title_fullStr Hepatitis B and C in dialysis units in Kosova
title_full_unstemmed Hepatitis B and C in dialysis units in Kosova
title_short Hepatitis B and C in dialysis units in Kosova
title_sort hepatitis b and c in dialysis units in kosova
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694791/
https://www.ncbi.nlm.nih.gov/pubmed/19497116
http://dx.doi.org/10.1186/1743-422X-6-72
work_keys_str_mv AT telakuskender hepatitisbandcindialysisunitsinkosova
AT fejzahajrullah hepatitisbandcindialysisunitsinkosova
AT eleziymer hepatitisbandcindialysisunitsinkosova
AT bicajteuta hepatitisbandcindialysisunitsinkosova